Aveanna Healthcare (NASDAQ:AVAH) Vs. FATE, PINC, HALO, HQY, PACB, CERE, AMED, OPCH, KOD, and INMD
Should you be buying Aveanna Healthcare stock or one of its competitors? The main competitors of Aveanna Healthcare include Fate Therapeutics (FATE), Premier (PINC), Halozyme Therapeutics (HALO), HealthEquity (HQY), Pacific Biosciences of California (PACB), Cerevel Therapeutics (CERE), Amedisys (AMED), Option Care Health (OPCH), Kodiak Sciences (KOD), and InMode (INMD). These companies are all part of the "home health care services" industry.These companies are all part of the "home health care services" industry.These companies are all part of the "medical" sector.
Aveanna Healthcare vs.
Aveanna Healthcare (NASDAQ:AVAH) and Premier (NASDAQ:PINC) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, community ranking, media sentiment, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.
68.1% of Aveanna Healthcare shares are held by institutional investors. Comparatively, 66.6% of Premier shares are held by institutional investors. 1.0% of Premier shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Aveanna Healthcare presently has a consensus price target of $13.75, indicating a potential upside of 118.95%. Premier has a consensus price target of $40.45, indicating a potential upside of 7.82%. Given Aveanna Healthcare's stronger consensus rating and higher possible upside, equities analysts clearly believe Aveanna Healthcare is more favorable than Premier.
In the previous week, Premier had 5 more articles in the media than Aveanna Healthcare. MarketBeat recorded 12 mentions for Premier and 7 mentions for Aveanna Healthcare. Premier's average media sentiment score of 0.16 beat Aveanna Healthcare's score of 0.10 indicating that Premier is being referred to more favorably in the news media.
Premier has a net margin of 15.17% compared to Aveanna Healthcare's net margin of 0.00%. Premier's return on equity of 12.64% beat Aveanna Healthcare's return on equity.
Premier has higher revenue and earnings than Aveanna Healthcare.
Premier received 551 more outperform votes than Aveanna Healthcare when rated by MarketBeat users. However, 82.61% of users gave Aveanna Healthcare an outperform vote while only 70.46% of users gave Premier an outperform vote.
Summary
Premier beats Aveanna Healthcare on 8 of the 14 factors compared between the two stocks.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding AVAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment >-1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aveanna Healthcare (NASDAQ:AVAH) vs. Its Competitors
Aveanna Healthcare Competitors List
